Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Hepatic visualization on iodine-131 whole-body thyroid cancer scans

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:5974228
This study examines the frequency and significance of diffuse liver uptake on /sup 131/I whole-body thyroid cancer scans. Sixty whole-body scans on 27 patients with differentiated thyroid cancer were reviewed. Liver uptake was quantitated on another 21 studies (16 patients). Diffuse hepatic uptake was seen in 44% of patients and 35% of all the studies. It correlated best with the /sup 131/I dose administered (r = 0.733) and the product of the /sup 131/I percent radioactive iodine uptake (RAIU) and administered dose (r = 0.656), less well with the serum /sup 131/I protein bound iodine (r = 0.494) and the RAIU. This study demonstrates that liver visualization is more common than generally appreciated and is related to the /sup 131/I dose and indices of thyroid function although other factors may also play a role in liver visualization.
Research Organization:
Georgetown Univ. Medical Center, Washington, DC
OSTI ID:
5974228
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 28:9; ISSN JNMEA
Country of Publication:
United States
Language:
English